New Age Alpha Advisors LLC Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

New Age Alpha Advisors LLC acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 423,274 shares of the pharmacy operator’s stock, valued at approximately $3,949,000.

Several other institutional investors have also recently added to or reduced their stakes in WBA. Quest Partners LLC grew its position in Walgreens Boots Alliance by 379.4% in the 3rd quarter. Quest Partners LLC now owns 10,499 shares of the pharmacy operator’s stock valued at $94,000 after acquiring an additional 8,309 shares in the last quarter. Intech Investment Management LLC acquired a new position in shares of Walgreens Boots Alliance in the third quarter valued at approximately $109,000. Great Valley Advisor Group Inc. acquired a new position in shares of Walgreens Boots Alliance in the third quarter valued at approximately $106,000. Pitcairn Co. purchased a new stake in Walgreens Boots Alliance during the 3rd quarter worth approximately $159,000. Finally, Larson Financial Group LLC lifted its holdings in Walgreens Boots Alliance by 49.9% during the 3rd quarter. Larson Financial Group LLC now owns 9,803 shares of the pharmacy operator’s stock worth $88,000 after buying an additional 3,264 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $11.19 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $21.74. The firm has a market capitalization of $9.67 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. The company’s fifty day moving average price is $10.83 and its 200 day moving average price is $9.90.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.66 EPS. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

WBA has been the topic of a number of recent research reports. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price target for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Finally, StockNews.com started coverage on shares of Walgreens Boots Alliance in a report on Wednesday. They issued a “hold” rating on the stock. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.